Skip to main content

Table 2 Body fat: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

Body fat (mean %)

Fat reduction (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

43.85 ± 5.60

42.04 ± 6.63a

-4.13‡

Formula A (↓dose)

40.22 ± 7.26

39.08 ± 6.12a

-2.83†

Placebo

42.28 ± 8.27

42.18 ± 8.117

-0.24

  1. ap < 0.05; bp < 0.001 compared with Placebo
  2. *p < 0.05; **p < 0.001 compared with Formula A
  3. †p < 0.05; ‡p < 0.001 compared with Initial; intragroup analysis
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X